Clinical trial
Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma
NCT03071705
Study timeline
Study start (unknown)2016-03-01Date precision: month
Registry last updated2017-03-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-Small Cell Adenocarcinomaunresolved
Tyrosine Kinase Mutationunresolved
EGFR Gene Mutationunresolved
Interventions
MetforminDRUG · verified · RxNorm: metformin
TKIDRUG
Sponsors & collaborators
Instituto Nacional de Cancerologia de Mexicolead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03071705 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.